|
She started her career as a management consultant, but Aubrie Pagano says she always knew she wanted to be an entrepreneur. And she was particularly energized by fashion.
So Pagano spent her free hours assisting local Boston designer Emily Muller in launching her... Read more »
Yo, is there a ballplayer in the house? Well, there is a House playing ball—professional basketball, that is.
At the age of 33, Adam House, a serial entrepreneur (and shooting guard) who has successfully built and sold three companies—his most recent startup, Velocitude, was acquired... Read more »
Plans for IPOs and venture funding dominated the New England deals news this week.
—A new seed fund, backed by venture firm New Enterprise Associates and hosted by Harvard, came out of the woodwork last week. The Experiment Fund will invest up... Read more »
At first glance, a report released last week by PricewaterhouseCoopers and the National Venture Capital Association seems to portend rich times for life sciences startups. Biotech companies raised $4.7 billion in 2011—more than any other sector except for software and enough... Read more »
Cambridge, MA-based Radius Health, which is on a quest to enter the multibillion-dollar market for osteoporosis treatments, said today it has filed to go public. The company hopes to raise $86 million in the proposed offering. The IPO will be underwritten... Read more »
In enterprise data centers, servers and storage go together like hot dogs and buns. One isn’t much good without the other. But if your specialty is baking buns, you probably don’t spend a lot of time thinking about how to improve the... Read more »
Applied Proteomics hasn’t exactly been operating in stealth mode since it was founded five years ago. Co-founders David Agus, a cancer specialist at USC, and Danny Hillis, the MIT-trained computer scientist, gave TedMed talks about the startup’s technology, which provides... Read more »
Managing Director, Project 11
Managing Dir. of Life Sciences, Hercules Technology Growth Capital
Founder and CEO of Wolfram Research
CEO, Alnylam Pharmaceuticals
Professor of Genetics, Harvard Medical School
Instructor in Pediatrics, Harvard Medical School
President and CEO, Millennium: The Takeda Oncology Company
Scientist and Managing Dir., Microsoft Research New England
Partner, Third Rock Ventures
Chairman and CEO, Nanobiosym Diagnostics Inc.
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
